Failures in direct purchases
Because UNOPS did not cover the remaining 2,435 keys, between June 22 and July 18, 2021, Insabi made direct purchases to acquire the missing supplies, but only considered 986 keys.
“It is concluded that all the needs for medicines and healing material of the Participating Public Institutions required to Insabi were not met,” said the ASF.
The IMSS had requested 1,149 drug codes, but in purchases with UNOPS only 662 were awarded and, for direct purchases led by Insabi, 389. In the case of ISSSTE, of 793 required codes, only 471 were awarded through purchases with UNOPS and 94 in direct awards from Insabi.
The auditing body detected that in these direct purchases two drug codes were awarded to one supplier, despite the fact that the best prices and the greatest production capacity were offered by two other suppliers. Insabi also bought a medicine from a supplier without a health license.
In three contracts for ISSSTE, derived from direct awards from Insabi, there was no documentation to support that the supplies have sanitary records and records from the Federal Commission for Protection against Sanitary Risks (Cofepris).
Nor was it documented that they complied with the Official Mexican and International Standards, nor with “the letter of commitment to guarantee compliance, against hidden defects and poor quality of the goods delivered; the expiration and exchange commitment letter, and the proof of registration to the single registry of suppliers and contractors”.
